The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
Open accessAbstract
BACKGROUND: The need for repeated treatment of restenosis of a treated vessel remains the main limitation of percutaneous coronary revascularization. Because sirolimus (rapamycin) inhibits the proliferation of lymphocytes and smooth-muscle cells, we compared a sirolimus-eluting stent with a standard uncoated stent in patients with angina pectoris. METHODS: We performed a randomized, double-blind trial to compare the two types of stents for revascularization of single, primary lesions in native coronary arteries. The trial included 238 patients at 19 medical centers. The primary end point was in-stent late luminal loss (the difference between the minimal luminal diameter immediately after the procedure and the diameter at six months). Secondary end points included the percentage of in-stent stenosis of the luminal diameter and the rate of restenosis (luminal narrowing of 50 percent or more). We also analyzed a composite clinical end point consisting of death, myocardial infarction, and percutaneous or surgical revascularization at 1, 6, and 12 months. RESULTS: At six months, the degree of neointimal proliferation, manifested as the mean (+/-SD) late luminal loss, was significantly lower in the sirolimus-stent group (-0.01+/-0.33 mm) than in the standard-stent group (0.80+/-0.53 mm, P<0.001). None of the patients in the sirolimus-stent group, as compared with 26.6 percent of those in the standard-stent group, had restenosis of 50 percent or more of the luminal diameter (P<0.001). There were no episodes of stent thrombosis. During a follow-up period of up to one year, the overall rate of major cardiac events was 5.8 percent in the sirolimus-stent group and 28.8 percent in the standard-stent group (P<0.001). The difference was due entirely to a higher rate of revascularization of the target vessel in the standard-stent group. CONCLUSIONS: As compared with a standard coronary stent, a sirolimus-eluting stent shows considerable promise for the prevention of neointimal proliferation, restenosis, and associated clinical events.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Serruys, P. W., de Jaegere, P., Kiemeneij, F., Macaya, C., Rutsch, W., Heyndrickx, G., Emanuelsson, H., Marco, J., Legrand, V., Materne, P., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408253310801 · Cited by 4,556
Self-citationFischman, D. L., Leon, M. B., Baim, D. S., Schatz, R. A., Savage, M. P., Penn, I., Detre, K., Veltri, L., Ricci, D., Nobuyoshi, M., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408253310802 · Cited by 4,271
Self-citationIntravascular Stents to Prevent Occlusion and Re-Stenosis after Transluminal Angioplasty
Sigwart, U., Puel, J., Mirkovitch, V., Joffre, F., & Kappenberger, L. (1987) · New England Journal of Medicine · doi:10.1056/nejm198703193161201 · Cited by 1,892
Letter: Grading of angina pectoris.
Campeau, L. (1976) · Circulation · doi:10.1161/circ.54.3.947585 · Cited by 1,601
Unstable angina. A classification.
Braunwald, E. (1989) · Circulation · doi:10.1161/01.cir.80.2.410 · Cited by 1,366
Patterns and Mechanisms of In-Stent Restenosis: A Serial Intravascular Ultrasound Study
Hoffmann, R., Mintz, G. S., Dussaillant, G. R., Popma, J. J., Pichard, A. D., Satler, L. F., Kent, K. M., Griffin, J., & Leon, M. B. (1996) · Circulation · doi:10.1161/01.cir.94.6.1247 · Cited by 1,247
Comparison of Coronary-Artery Bypass Surgery and Stenting for the Treatment of Multivessel Disease
Serruys, P. W., Unger, F., Sousa, J. E., Jatene, A., Bonnier, H. J. R. M., Schönberger, J. P. A. M., Buller, N., Bonser, R., van den Brand, M. J. B., van Herwerden, L. A., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104123441502 · Cited by 1,114
Self-citationHolmes, D. R., Vlietstra, R. E., Smith, H. C., Vetrovec, G. W., Kent, K. M., Cowley, M. J., Faxon, D. P., Gruentzig, A. R., Kelsey, S. F., Detre, K. M., et al. (1984) · The American Journal of Cardiology · doi:10.1016/0002-9149(84)90752-5 · Cited by 1,113
Catheter-Based Radiotherapy to Inhibit Restenosis after Coronary Stenting
Teirstein, P. S., Massullo, V., Jani, S., Popma, J. J., Mintz, G. S., Russo, R. J., Schatz, R. A., Guarneri, E. M., Steuterman, S., Morris, N. B., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706123362402 · Cited by 942
Sousa, J. E., Costa, M. A., Abizaid, A., Abizaid, A. S., Feres, F., Pinto, I. M. F., Seixas, A. C., Staico, R., Mattos, L. A., Sousa, A. G. M. R., et al. (2001) · Circulation · doi:10.1161/01.cir.103.2.192 · Cited by 793
Self-citation
Cited by
Items 101–142 of 142
Anti-inflammatory and immunomodulatory effects of statins
Blanco-Colio, L. M., Tuñón, J., Martín-Ventura, J. L., & Egido, J. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00744.x · Cited by 347
Arterial Wall Shear Stress: Observations from the Bench to the Bedside
Paszkowiak, J. J., & Dardik, A. (2003) · Vascular and Endovascular Surgery · doi:10.1177/153857440303700107 · Cited by 344
Kaiser, C., Brunner-La Rocca, H. P., Buser, P. T., Bonetti, P. O., Osswald, S., Linka, A., Bernheim, A., Zutter, A., Zellweger, M., Grize, L., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67221-2 · Cited by 342
Ong, A. T. L., Serruys, P. W., Mohr, F. W., Morice, M.-C., Kappetein, A. P., Holmes, D. R., Mack, M. J., van den Brand, M., Morel, M.-A., van Es, G.-A., et al. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.07.017 · Cited by 338
Self-citationFolate Therapy and In-Stent Restenosis after Coronary Stenting
Lange, H., Suryapranata, H., De Luca, G., Börner, C., Dille, J., Kallmayer, K., Pasalary, M. N., Scherer, E., & Dambrink, J.-H. E. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032845 · Cited by 336
Evolving concepts of angiogram: fractional flow reserve discordances in 4000 coronary stenoses
Toth, G., Hamilos, M., Pyxaras, S., Mangiacapra, F., Nelis, O., De Vroey, F., Di Serafino, L., Muller, O., Van Mieghem, C., Wyffels, E., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu094 · Cited by 329
Norhammar, A., Malmberg, K., Diderholm, E., Lagerqvist, B., Lindahl, B., Rydén, L., & Wallentin, L. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.08.050 · Cited by 328
Chronic Coronary Artery Disease: Diagnosis and Management
Cassar, A., Holmes, D. R., Rihal, C. S., & Gersh, B. J. (2009) · Mayo Clinic Proceedings · doi:10.4065/mcp.2009.0391 · Cited by 324
Urban, P., Gershlick, A. H., Guagliumi, G., Guyon, P., Lotan, C., Schofer, J., Seth, A., Sousa, J. E., Wijns, W., Berge, C., et al. (2006) · Circulation · doi:10.1161/circulationaha.104.532242 · Cited by 322
Self-citationCoronary stents: historical development, current status and future directions
Iqbal, J., Gunn, J., & Serruys, P. W. (2013) · British Medical Bulletin · doi:10.1093/bmb/ldt009 · Cited by 319
Self-citationArdissino, D., Cavallini, C., Bramucci, E., Indolfi, C., Marzocchi, A., Manari, A., Angeloni, G., Carosio, G., Bonizzoni, E., Colusso, S., et al. (2004) · JAMA · doi:10.1001/jama.292.22.2727 · Cited by 314
Kastrati, A., Dibra, A., Mehilli, J., Mayer, S., Pinieck, S., Pache, J., Dirschinger, J., & Schömig, A. (2006) · Circulation · doi:10.1161/circulationaha.105.601823 · Cited by 312
Chieffo, A., Morici, N., Maisano, F., Bonizzoni, E., Cosgrave, J., Montorfano, M., Airoldi, F., Carlino, M., Michev, I., Melzi, G., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.595694 · Cited by 310
Self-citationACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention—Summary Article
Smith, S. C., Feldman, T. E., Hirshfeld, J. W., Jacobs, A. K., Kern, M. J., King, S. B., Morrison, D. A., O’Neill, W. W., Schaff, H. V., Whitlow, P. L., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.11.025 · Cited by 310
Ormiston, J. A., & Serruys, P. W. S. (2009) · Circulation: Cardiovascular Interventions · doi:10.1161/circinterventions.109.859173 · Cited by 305
Self-citationSerruys, P. W., Garcia-Garcia, H. M., & Onuma, Y. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr384 · Cited by 303
Self-citationCollet, J.-P., Silvain, J., Barthélémy, O., Rangé, G., Cayla, G., Van Belle, E., Cuisset, T., Elhadad, S., Schiele, F., Lhoest, N., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60612-7 · Cited by 303
Beyond Restenosis: Five-Year Clinical Outcomes From Second-Generation Coronary Stent Trials
Cutlip, D. E., Chhabra, A. G., Baim, D. S., Chauhan, M. S., Marulkar, S., Massaro, J., Bakhai, A., Cohen, D. J., Kuntz, R. E., & Ho, K. K. L. (2004) · Circulation · doi:10.1161/01.cir.0000140721.27004.4b · Cited by 302
Drug eluting stents: are human and animal studies comparable?
Virmani, R., Kolodgie, F. D., Farb, A., & Lafont, A. (2003) · Heart · doi:10.1136/heart.89.2.133 · Cited by 300
The evolving role of platelets in inflammation
Weyrich, A. S., Lindemann, S., & Zimmerman, G. A. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00304.x · Cited by 294
Hassan, A. K. M., Bergheanu, S. C., Stijnen, T., van der Hoeven, B. L., Snoep, J. D., Plevier, J. W. M., Schalij, M. J., & Wouter Jukema, J. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehn553 · Cited by 290
Lemos, P. A., Saia, F., Ligthart, J. M. R., Arampatzis, C. A., Sianos, G., Tanabe, K., Hoye, A., Degertekin, M., Daemen, J., McFadden, E., et al. (2003) · Circulation · doi:10.1161/01.cir.0000083366.33686.11 · Cited by 286
Self-citationLee, C. W., Ahn, J.-M., Park, D.-W., Kang, S.-J., Lee, S.-W., Kim, Y.-H., Park, S.-W., Han, S., Lee, S.-G., Seong, I.-W., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.003303 · Cited by 284
Kastrati, A., Dibra, A., Eberle, S., Mehilli, J., Suárez de Lezo, J., Goy, J.-J., Ulm, K., & Schömig, A. (2005) · JAMA · doi:10.1001/jama.294.7.819 · Cited by 282
CARTER, A. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.04.029 · Cited by 281
A Comparison of Bare-Metal and Drug-Eluting Stents for Off-Label Indications
Marroquin, O. C., Selzer, F., Mulukutla, S. R., Williams, D. O., Vlachos, H. A., Wilensky, R. L., Tanguay, J.-F., Holper, E. M., Abbott, J. D., Lee, J. S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706258 · Cited by 270
Bioresorbable scaffolds: rationale, current status, challenges, and future
Iqbal, J., Onuma, Y., Ormiston, J., Abizaid, A., Waksman, R., & Serruys, P. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht542 · Cited by 269
Self-citationUnanswered Questions — Drug-Eluting Stents and the Risk of Late Thrombosis
Maisel, W. H. (2007) · New England Journal of Medicine · doi:10.1056/nejmp068305 · Cited by 268
Vermeersch, P., Agostoni, P., Verheye, S., Van den Heuvel, P., Convens, C., Van den Branden, F., & Van Langenhove, G. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.05.010 · Cited by 264
Impact of the Everolimus-Eluting Stent on Stent Thrombosis
Baber, U., Mehran, R., Sharma, S. K., Brar, S., Yu, J., Suh, J.-W., Kim, H.-S., Park, S.-J., Kastrati, A., de Waha, A., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.049 · Cited by 263
Jensen, L. O., Maeng, M., Kaltoft, A., Thayssen, P., Hansen, H. H. T., Bottcher, M., Lassen, J. F., Krussel, L. R., Rasmussen, K., Hansen, K. N., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.06.002 · Cited by 263
Akhter, N., Milford-Beland, S., Roe, M. T., Piana, R. N., Kao, J., & Shroff, A. (2009) · American Heart Journal · doi:10.1016/j.ahj.2008.08.012 · Cited by 260
Vermeersch, P., Agostoni, P., Verheye, S., Van den Heuvel, P., Convens, C., Bruining, N., Van den Branden, F., & Van Langenhove, G. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.09.021 · Cited by 256
Redox regulation of the nutrient-sensitive raptor-mTOR pathway and complex
Sarbassov, D. D., & Sabatini, D. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506096200 · Cited by 248
Research Progress of Shape Memory Polymer and 4D Printing in Biomedical Application
Zhao, W., Yue, C., Liu, L., Liu, Y., & Leng, J. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202201975 · Cited by 183
New concepts in the design of drug-eluting coronary stents
Garg, S., Bourantas, C., & Serruys, P. W. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.13 · Cited by 125
Self-citationmTORC Inhibitors as Broad-Spectrum Therapeutics for Age-Related Diseases
Walters, H. E., & Cox, L. S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082325 · Cited by 85
Sofroniadou, S., & Goldsmith, D. (2011) · Drug Safety · doi:10.2165/11585040-000000000-00000 · Cited by 60
Ribichini, F., Tomai, F., De Luca, G., Boccuzzi, G., Presbitero, P., Pesarini, G., Ferrero, V., Ghini, A. S., Abukaresh, R., Aurigemma, C., et al. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.11.027 · Cited by 31
Ito, T., Fujita, H., Tani, T., & Ohte, N. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.01.026 · Cited by 30
“Several randomized clinical trials have shown that drug-eluting stents (DES) substantially reduce angiographic restenosis and the need for repeat revascularization [1,2].”
BackgroundNitric oxide and nitrite-based therapeutic opportunities in intimal hyperplasia
Alef, M. J., Tzeng, E., & Zuckerbraun, B. S. (2012) · Nitric Oxide · doi:10.1016/j.niox.2012.03.014 · Cited by 20
Bioresorbable Stents: Is This Where We Are Headed?
Wayangankar, S. A., & Ellis, S. G. (2015) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2015.08.011 · Cited by 18
Metadata
- Authors
- Morice, M.-C., Serruys, P. W., Sousa, J. E., Fajadet, J., Ban Hayashi, E., Perin, M., Colombo, A., Schuler, G., Barragan, P., Guagliumi, G., Molnàr, F., & Falotico, R.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2002-06-06
- Volume
- 346
- Issue
- 23
- Pages
- 1773-1780
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2079818105
- Cited by
- 4,033
- References
- 20
- FWCI
- 333.34
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.